Fulton Breakefield Broenniman LLC Has $435,000 Holdings in Synopsys, Inc. (NASDAQ:SNPS)

Fulton Breakefield Broenniman LLC lessened its stake in Synopsys, Inc. (NASDAQ:SNPS) by 19.6% in the 4th quarter, Holdings Channel reports. The institutional investor owned 845 shares of the semiconductor company’s stock after selling 206 shares during the quarter. Fulton Breakefield Broenniman LLC’s holdings in Synopsys were worth $435,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Headlands Technologies LLC boosted its holdings in Synopsys by 300.6% during the fourth quarter. Headlands Technologies LLC now owns 7,135 shares of the semiconductor company’s stock worth $3,674,000 after purchasing an additional 5,354 shares during the last quarter. Kovack Advisors Inc. boosted its holdings in Synopsys by 17.8% during the fourth quarter. Kovack Advisors Inc. now owns 1,024 shares of the semiconductor company’s stock worth $527,000 after purchasing an additional 155 shares during the last quarter. Motley Fool Asset Management LLC boosted its holdings in Synopsys by 5.5% during the fourth quarter. Motley Fool Asset Management LLC now owns 4,598 shares of the semiconductor company’s stock worth $2,368,000 after purchasing an additional 239 shares during the last quarter. Semanteon Capital Management LP acquired a new position in Synopsys during the fourth quarter worth $1,161,000. Finally, Stevens Capital Management LP acquired a new stake in Synopsys during the fourth quarter worth about $2,450,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. StockNews.com upgraded shares of Synopsys from a “hold” rating to a “buy” rating in a research note on Monday, March 18th. Needham & Company LLC reiterated a “buy” rating and set a $660.00 price objective on shares of Synopsys in a research note on Friday, March 22nd. Rosenblatt Securities reiterated a “buy” rating and set a $615.00 price objective on shares of Synopsys in a research note on Thursday, March 21st. Robert W. Baird increased their price objective on shares of Synopsys from $624.00 to $640.00 and gave the stock an “outperform” rating in a research note on Thursday, February 22nd. Finally, Piper Sandler assumed coverage on shares of Synopsys in a research note on Thursday, April 4th. They set an “overweight” rating and a $665.00 price objective on the stock. Eleven equities research analysts have rated the stock with a buy rating, According to MarketBeat, Synopsys has a consensus rating of “Buy” and a consensus price target of $601.00.

Synopsys Stock Performance

Shares of SNPS traded up $13.55 during mid-day trading on Friday, reaching $543.66. The company had a trading volume of 997,562 shares, compared to its average volume of 908,153. The company’s 50 day simple moving average is $563.73 and its 200 day simple moving average is $535.97. Synopsys, Inc. has a 1-year low of $362.06 and a 1-year high of $629.38. The company has a market capitalization of $82.91 billion, a price-to-earnings ratio of 59.87, a P/E/G ratio of 3.10 and a beta of 1.06.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Wednesday, February 21st. The semiconductor company reported $3.56 EPS for the quarter, topping the consensus estimate of $3.43 by $0.13. Synopsys had a net margin of 22.96% and a return on equity of 22.88%. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same period last year, the company earned $1.75 EPS. The firm’s revenue was up 21.1% compared to the same quarter last year. As a group, equities analysts forecast that Synopsys, Inc. will post 9.78 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider John F. Runkel, Jr. sold 5,319 shares of Synopsys stock in a transaction that occurred on Wednesday, April 3rd. The shares were sold at an average price of $579.37, for a total transaction of $3,081,669.03. Following the sale, the insider now directly owns 20,000 shares in the company, valued at approximately $11,587,400. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Synopsys news, Director Roy Vallee sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $572.66, for a total transaction of $5,726,600.00. Following the completion of the transaction, the director now owns 20,000 shares in the company, valued at approximately $11,453,200. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider John F. Runkel, Jr. sold 5,319 shares of the firm’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $579.37, for a total transaction of $3,081,669.03. Following the transaction, the insider now owns 20,000 shares of the company’s stock, valued at approximately $11,587,400. The disclosure for this sale can be found here. Insiders have sold a total of 26,832 shares of company stock worth $15,464,992 in the last ninety days. Company insiders own 0.66% of the company’s stock.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.